Articles and Videos
Benzinga All Access: Guest Speaker Shane Johnson, BayMedica GM
Dr. Shane Johnson, SVP and GM of BayMedica, InMed's subsidiary, joins Benzinga's All Access Conference on June 17, 2022. Dr. Johnson talks about how manufacturing...
Source: Benzinga All Access
Scientific study on the biological activity of rare cannabinoids and their potential role on skin conditions published in peer-reviewed article
A peer-reviewed scientific study entitled “Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes” has been published in the International Journal of Molecular Sciences....
The Dales Report: InMed Pharmaceuticals: Commercializing The Development Of Rare Cannabinoids For The Wellness Market
Shadd Dales of The Dales Report interviews InMed CEO, Eric A. Adams, about the rare cannabinoid market and being able to manufacture rare cannabinoids like...
Edison: Cannabinoid manufacturing – Innovative approaches to the production of cannabinoids
InMed featured in this article about the different cannabinoid manufacturing technologies that are shaping the industry. The article by Edison also talks about the cannabinoid...
Fly exclusive interview with CEO Eric Adams
Leading digital financial news publisher "The Fly" gets an update on the launch of InMed's rare cannabinoid products and progress of our programs from CEO Eric A....
Empowered Patient Podcast: Manufacturing Bioidentical Rare Cannabinoids to Treat Glaucoma and Rare Skin Disease with Eric Adams InMed Pharmaceuticals
Empowered Patient Podcast Host Karen Jagoda speaks with InMed CEO Eric A. Adams about the company's cannabinol programs in glaucoma and epidermolysis bullosa. Excerpt: Eric...
